Global Apheresis Equipment Market 2016-2024: Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
DUBLIN, Oct. 06, 2017 /PRNewswire/ --
The "Apheresis Equipment - Global Strategic Business Report" report has been added to Research and Markets' offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment:
- Equipment for Therapeutic Apheresis
- Equipment for Donor Apheresis.
The Global market is additionally analyzed by the following Procedures:
- Photopheresis
- Plasmapheresis
- Others
The report profiles 14 companies including many key and niche players such as:
- Asahi Kasei Medical Co., Ltd. (Japan)
- B Braun Melsungen AG (Germany)
- Cerus Corporation (USA)
- Fresenius Kabi (Germany)
- Haemonetics Corporation (USA)
- Kaneka Corporation (Japan)
- Kawasumi Laboratories, Inc. (Japan)
- Mallinckrodt Pharmaceuticals (Ireland)
- Medica SpA (Italy)
- NIKKISO Europe GmbH (Germany)
- Terumo BCT, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Apheresis Equipment - Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
- Donor Apheresis & Therapeutic Apheresis
- Donor Apheresis: Dominating Equipment Sales
- Therapeutic Apheresis to Witness Strong Growth
- Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
- Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
- Plasmapheresis Systems Dominate Apheresis Equipment Market
- Neurology - The Major Application Area for Apheresis Equipment
- Developed Markets Continue to Lead Apheresis Equipment Market
- Developing Nations to Lead the Charge in Future
- Rising Demand for Plasma from Biopharmaceutical Companies
- Opportunity to Tap
- Sustained Growth in Blood Collections Favors Apheresis Equipment Market
- Competitive Landscape
- Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers
2. KEY MARKET TRENDS & DRIVERS
- Rising Cancer Incidence to Drive Volume of Apheresis Procedures
- Technological Advancements and Novel Indications Augur Well for Apheresis Market
- Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
- Photopheresis: A Popular Therapeutic Apheresis Procedure
- Plasmapheresis Continues to Lead the Apheresis Market
- Plateletpheresis Emerges as the Treatment of Choice'
- Increase in Number of Platelet Donors Drives Apheresis Procedures
- Pediatrics: An Unexplored Domain in Therapeutic Apheresis
- Automated Blood Processing Systems in Open Heart Surgeries
- CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
- Improving Healthcare Expenditure to Drive Demand
- Aging Population: A Strong Growth Driver
- Key Challenges & Issues
- Lack of Awareness among Patients Restrains Market Growth
- Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
- Development of Inexpensive Apheresis Therapies
- Shortage of Qualified Donors
- Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment
3. TECHNOLOGY OVERVIEW
- Apheresis - The Definition
- Apheresis Vs Whole Blood Collection
- Comparison of Apheresis and Whole Blood Collection
- The Process of Apheresis - An Overview
- Blood Components
- Apheresis Procedure
- Duration, Frequency, and Efficiency of Apheresis
- Segregation of Blood Components
- Centrifugation
- Centrifugal Cell Separators
- Filtration
- Side Effects
- Types of Apheresis Procedures
- Plasmapheresis
- Plasma Exchange and Plasmapheresis: The Difference
- Therapeutic Plasma Exchange (TPE) or Plasma Exchange
- TPE: Abnormal Components Removed from Blood
- Plasmapheresis: Potential Uses Discovered in the Early Years
- Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
- Erythrocytapheresis
- Plateletpheresis
- Leukapheresis
- Photopheresis
- Functioning of THERAKOS - A Typical Photopheresis System
- Lipidpheresis
- Cytapheresis
- Stem Cell Collection
- Apheresis - A Review of Segmentation
- Donor Apheresis
- Process of Donor Apheresis
- Automated Blood Donation Procedures
- Safety of the Donor
- Blood Components Required by Different Patients
- Automated Apheresis
- Therapeutic Apheresis: An Introduction
- Therapeutic Apheresis Techniques
- Applications of Therapeutic Apheresis
- Categories of Indications for Therapeutic Apheresis
- Therapeutic Apheresis is Remedial for Various Diseases
- Indications for Therapeutic Apheresis
- Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
- Emerging Applications of Therapeutic Apheresis
- Cost of Select Therapeutic Apheresis Procedures: An Overview
1. Photopheresis in GVHD (Graft-Versus-Host Disease)
2. Lipid Apheresis (LDL Apheresis)
3. Plasmapheresis and Other Procedures
- Therapeutic Apheresis: What is the Risk Involved?
- Replacement Fluid in Therapeutic Apheresis
- Replacement Fluids Used in Therapeutic Apheresis
- Various Replacement Fluids in Use
- Select Replacement Fluids and their Limitations
- Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
- Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement
4. BLOOD COMPONENTS & DERIVATIVES
- Red Blood Cells (RBCs)
- White Blood Cells (WBCs)
- Platelets
- Sources of Blood Plasma
- Facts About Plasma and its Donation
- Pre-requisites for Plasma Donors
- The Complex Process of Becoming a Donor
- Medical Screening
- The Process of Plasma Donation
- Select IQPP-authorized Plasma Collection Centers (US)
- Ionic Composition of Blood
- Types of Blood
- General Facts about Blood
- General Uses of Blood
- Blood - Global Facts
5. PRODUCT INNOVATIONS/INTRODUCTIONS
- Fresenius Introduces 6008 CAREsystem
- Terumo BCT Launches Correct Connect System
- FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
- Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
- USFDA Clears PMN Protocol for Terumo's Spectra Optia
6. RECENT INDUSTRY ACTIVITY
- Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
- Terumo BCT Receives CE Mark for Spectra Optia Apheresis System
- Terumo BCT Enters into Distribution Agreement with B Medical Systems
- Mallinckrodt Takes Over Therakos
- HemaCare Sells Therapeutic Apheresis Assets to Fresenius
- Terumo BCT Files FDA Submission to Improve Blood Supply Safety
- Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
- Terumo opens Production Facility in Vietnam
- Terumo Collaborates with Kaneka
- Terumo to Distribute Therakos Products in Latin America
- Terumo Enters Distribution Agreement with Therakos
7. FOCUS ON SELECT PLAYERS
- Asahi Kasei Medical Co., Ltd. (Japan)
- B Braun Melsungen AG (Germany)
- Cerus Corporation (USA)
- Fresenius Kabi (Germany)
- Haemonetics Corporation (USA)
- Kaneka Corporation (Japan)
- Kawasumi Laboratories, Inc. (Japan)
- Mallinckrodt Pharmaceuticals (Ireland)
- Medica SpA (Italy)
- NIKKISO Europe GmbH (Germany)
- Terumo BCT, Inc. (USA)
8. GLOBAL MARKET PERSPECTIVE
For more information about this report visit https://www.researchandmarkets.com/research/mc4r97/apheresis
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article